GLP-1 · Bilingual Telehealth · FL
Miami is the cultural capital of Latino America in the US, with over 310,000 Hispanic residents — 72% of the population. REMEVi feels right at home here: our bilingual platform connects Miami women with Florida-licensed physicians for GLP-1 weight loss treatments at transparent prices, with no insurance required.
Free · about 1 minute · no card required
72% of Miami is Latino. Finally, there's a telehealth platform that reflects your community.
Miami · Miami-Dade County
Miami has one of the largest and most diverse Hispanic populations in the country — Cuban, Venezuelan, Colombian, Nicaraguan, and Dominican, among many others. Despite this diversity, many obesity medicine clinics require referrals, specific insurance, or long waitlists. REMEVi operates fully bilingually with Florida-licensed physicians who see cash-pay patients from Hialeah to Coral Gables, from Doral to Little Havana. Intake takes 5 minutes, medical review happens in 24 hours, and medication arrives discreetly at your door.
Miami's Hispanic and Latino community — over 310,000+ residents — spans Mexican, Cuban, Puerto Rican, Central American, and South American roots, each with its own food traditions, family dynamics, and relationship with the US healthcare system. What's consistent across all of them: being understood without a translator, without cultural assumptions, and without having to explain why arroz con frijoles isn't a "problem to eliminate" but a reality to integrate into a sustainable weight loss plan.
Across Miami-Dade County, roughly 22.4% of adults live with obesity. For Latinas, the numbers are steeper — elevated rates of type 2 diabetes, metabolic syndrome, and insulin resistance combine with cultural and linguistic barriers that slow access to endocrinology and obesity specialists. GLP-1 medications (semaglutide and tirzepatide) are among the most studied and effective tools we have today, but they only work when the patient can speak to their licensed provider in their own language.
One flat price at every dose. Most weight-loss programs raise your price every time your dose goes up — REMEVi never does. Visit, medication, coaching and shipping — one number. No separate membership fee. (Many programs add a $79–$149/mo membership on top of the medication price.)
Provider-managed weekly injection. The same compounded GLP-1 as the big-brand competitors — with bilingual care, no insurance, no dose upcharges.
Daily oral semaglutide. Same clinical oversight, same bilingual care — without the needle.
Dual-agonist tirzepatide. The strongest average loss in the GLP-1 category — provider-managed, bilingual care.
¹ Clinical-trial results for semaglutide (STEP-1, NEJM 2021) and tirzepatide (SURMOUNT-1, NEJM 2022) — the active medications in REMEVi protocols, not REMEVi outcomes or guarantees. Compounded preparations are not FDA-approved and have not been studied as finished products. Individual results vary.
How It Works · Cómo Funciona
From intake to medication in days, not weeks. Bilingual throughout.
100% private, from your phone. English or Spanish. If you qualify, a 5-minute medical intake follows.
A Florida-licensed clinician reviews your history and confirms candidacy.
Free overnight cold-chain shipping, discreetly packaged, to your Miami address.
Dose adjustments, coaching, and ongoing support — bilingual throughout.
The Care Team
The licensed providers treating patients through REMEVi are actively licensed in Florida, board-certified, with experience across endocrinology, internal medicine, and obesity medicine. Every provider holds an NPI (National Provider Identifier) verifiable in the federal registry.
On safety and privacy: REMEVi is 100% HIPAA-compliant. Your medical information is never sold, never shared with insurance companies, and never used for advertising. Our compounding pharmacies are state-licensed and our clinical operations follow FDA and state medical board guidelines.
FAQ
Clear answers on GLP-1, telemedicine, and how REMEVi works in Miami.
Yes. Telemedicine is fully legal in Florida. All licensed providers working with REMEVi hold active Florida medical licenses and comply with state telemedicine regulations, federal HIPAA law, and FDA prescribing guidelines.
After your provider approves your plan (typically within 24 hours of intake), your medication ships within 48 hours from a state-licensed compounding pharmacy with free overnight cold-chain shipping to your Miami address. All shipments are discreet — no labels identifying the contents.
REMEVi's compounded semaglutide and compounded tirzepatide are not the same as, and are not generic versions of, Ozempic®, Wegovy®, Mounjaro®, or Zepbound®. Those branded products are FDA-approved finished drugs manufactured by Novo Nordisk and Eli Lilly. REMEVi's compounded preparations are non-FDA-approved and are prepared by state-licensed US compounding pharmacies under individual prescriptions from licensed US providers. Compounded preparations have not been clinically studied as finished products. Your licensed provider will review the risks, benefits, and considerations with you before prescribing.
No. REMEVi is a direct-pay service with 100% transparent pricing — we don't accept insurance and don't file claims. The price you see is the price you pay. This also means your medical information is never shared with insurance companies.
Yes. REMEVi was built bilingual from day one. Spanish isn't auto-translation — it's our native voice. Your intake, your provider, your educational materials, and your ongoing support are all available in Spanish with no delays, no third-party translators, and no compromise in care quality.
REMEVi serves all of Florida, not just Miami. If you live anywhere in Florida and we have a licensed provider there (we do), we can treat you. Shipping reaches residential addresses and PO boxes alike.
Yes. The monthly plan has no contract — pause or cancel anytime from your patient dashboard with no penalties. The prepaid 12-week and 52-week plans simply don't renew at the end of their term; see our Cancellation & Refund Policy for early-cancellation details.
GLP-1s (semaglutide and tirzepatide) have been extensively studied for over a decade and are FDA-approved for type 2 diabetes and weight loss. Most common side effects are mild nausea, stomach upset, and constipation during the first few weeks. Your bilingual provider titrates the dose gradually to minimize these effects. Before prescribing, we review your full medical history to rule out contraindications.
Locations · Ubicaciones
REMEVi serves patients in Florida and across the US. Same bilingual care: semaglutide $149 first month, tirzepatide $249 first month — or as low as $199/mo and $269/mo on 52-week plans, all-inclusive.
Take the free 1-minute quiz. A Florida-licensed bilingual clinician reviews your case within 24 hours.
See if you qualifyFree · about 1 minute · no card required
What GLP-1 is, how it works, what to expect, and nutrition tips — in English and Spanish. Free, straight to your inbox.
No spam. Unsubscribe anytime.
Free · no card required
